Wound Repair Regen:PRF可有效促进大疱性皮肤病引起的口腔溃疡的愈合

2022-08-03 MedSci原创 MedSci原创

对口腔黏膜炎患者的管理,几十年来一直以局部类固醇为目标,口腔医学专家普遍认为,这是许多口腔溃疡的黄金治疗线。

对口腔黏膜炎患者的管理,几十年来一直以局部类固醇为目标,口腔医学专家普遍认为,这是许多口腔溃疡的黄金治疗线。大疱性皮肤病所导致的长期的口腔溃疡对类固醇的治疗反应较差,是与口腔粘膜炎和溃疡有关的免疫介导疾病。 PRF是血小板浓缩物之一,含有15种以上的生长因子,包括EGF、集落刺激生长因子、VEGF、血小板衍生生长。PRF已被证明可以通过对组织驻留的间充质细胞发出信号来促进软组织的愈合和再生。近日,发表于Wound Repair Regen的一项随机、对照、试验性临床试验旨在评估富含血小板的纤维蛋白(PRF)在疼痛控制和粘膜修复方面的愈合能力。

研究共纳入了16名受试者(4名SJS患者,4名BMMP患者,8名PV患者),以1:1的分配比例随机分为两组:治疗组接受PRF+orabase混合,对照组接受0.05%丙酸氯倍他索+orabase混合。两种治疗方法都以相同的剂量应用,每天三次,持续1周。治疗重复进行,直到达到完全愈合(疼痛和粘膜炎零分),预计在28天内完全愈合。疼痛减轻作为主要结果进行评估,粘膜炎愈合作为次要结果。

 

结果显示,在两组之间观察到疼痛减少的统计学差异(P≤0.05)。第7天的临床结果显示,PRF组的疼痛减少了100%,而CP组在基准线上减少了32.5%(P≤0.05)。与皮质类固醇相比,PRF提供了卓越的临床效果,迅速缓解了疼痛并加速了溃疡的愈合,尤其是对SJS患者。

综上所述,该研究结果表明,与经典的局部类固醇治疗相比,PRF促进了因大疱性皮肤病引起的粘膜炎患者的加速愈合。因此,在处理不同系统疾病引起的口腔粘膜炎时,或可使用生长因子来诱导组织的修复和再生。

原始出处:

Eman M Ahmed, et al., Platelet-rich fibrin a new approach in management of persistent oral ulcers in blistering skin diseases. Wound Repair Regen. 2022 Jul;30(4):491-497. doi: 10.1111/wrr.13020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826177, encodeId=a82d18261e7b7, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sat Apr 15 20:36:10 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236279, encodeId=666a12362e94c, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Wed Aug 03 09:37:45 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427609, encodeId=5f10142e609f9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581337, encodeId=c353158133e48, content=<a href='/topic/show?id=f8341466954' target=_blank style='color:#2F92EE;'>#PRF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14669, encryptionId=f8341466954, topicName=PRF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6716763517, createdName=12498b3em13(暂无昵称), createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826177, encodeId=a82d18261e7b7, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sat Apr 15 20:36:10 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236279, encodeId=666a12362e94c, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Wed Aug 03 09:37:45 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427609, encodeId=5f10142e609f9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581337, encodeId=c353158133e48, content=<a href='/topic/show?id=f8341466954' target=_blank style='color:#2F92EE;'>#PRF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14669, encryptionId=f8341466954, topicName=PRF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6716763517, createdName=12498b3em13(暂无昵称), createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=)]
    2022-08-03 九针
  3. [GetPortalCommentsPageByObjectIdResponse(id=1826177, encodeId=a82d18261e7b7, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sat Apr 15 20:36:10 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236279, encodeId=666a12362e94c, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Wed Aug 03 09:37:45 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427609, encodeId=5f10142e609f9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581337, encodeId=c353158133e48, content=<a href='/topic/show?id=f8341466954' target=_blank style='color:#2F92EE;'>#PRF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14669, encryptionId=f8341466954, topicName=PRF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6716763517, createdName=12498b3em13(暂无昵称), createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=)]
    2022-07-31 gwc384
  4. [GetPortalCommentsPageByObjectIdResponse(id=1826177, encodeId=a82d18261e7b7, content=<a href='/topic/show?id=f6a6e206066' target=_blank style='color:#2F92EE;'>#皮肤病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72060, encryptionId=f6a6e206066, topicName=皮肤病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sat Apr 15 20:36:10 CST 2023, time=2023-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236279, encodeId=666a12362e94c, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuK8xaPxppo2XKQOl7V2UpTUB7nNKxgsyjiaNh335icZebElyjYs0AlQy5tibgrJRnqnQbw3ZuXeoWSt/0, createdBy=ffed2050909, createdName=九针, createdTime=Wed Aug 03 09:37:45 CST 2022, time=2022-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1427609, encodeId=5f10142e609f9, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581337, encodeId=c353158133e48, content=<a href='/topic/show?id=f8341466954' target=_blank style='color:#2F92EE;'>#PRF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14669, encryptionId=f8341466954, topicName=PRF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6716763517, createdName=12498b3em13(暂无昵称), createdTime=Sun Jul 31 14:36:10 CST 2022, time=2022-07-31, status=1, ipAttribution=)]

相关资讯

男子腹痛,又有口腔溃疡,原以为是梅毒,万万没想到……医生害怕了!

这两天汪某无缘无故出现肚子痛,主要是下腹痛,隐痛为主,不剧烈,但难受,起初以为是吃错了东西,在药店买点整肠丸吃,没效果。

NEJM:Apremilast治疗白塞病相关口腔溃疡

研究发现,在与白塞病综合征相关的口腔溃疡患者中,Apremilast可减少口腔溃疡数量,改善患者生活质量

Celgene的Otezla成为美国**白塞病综合征口腔溃疡的治疗方法

Celgene周五(2019年7月19日)宣布,FDA扩大了PDE4抑制剂Otezla(apremilast)的适应症范围,允许Otezla治疗白塞病综合征口腔溃疡。

Clin Oral Investig:二极管激光是治疗白塞氏病相关口腔溃疡的高效安全治疗方式

白塞氏病表现为复发性口腔溃疡、生殖器溃疡和虹膜炎三联症,是一种慢性、复发性、多系统的炎症性疾病。药物局部治疗通常被用作口腔溃疡的一线治疗,近些年激光成为口腔溃疡及相关病变的一种安全的替代治疗方式。

除了溶栓降压治痴呆,ta还能让口腔溃疡患者吃嘛嘛香?

BMC Oral Health:纳豆激酶粗提物促进口腔黏膜炎愈合

什么是白塞病?可出现5大异常表现,别无视了

记住这5大临床表现,可以帮助诊疗。